Article

Radiation-Induced Carcinogenesis: Mechanistically Based Differences between Gamma-Rays and Neutrons, and Interactions with DMBA

Center for Radiological Research, Columbia University Medical Center, New York, New York, United States of America.
PLoS ONE (Impact Factor: 3.53). 12/2011; 6(12):e28559. DOI: 10.1371/journal.pone.0028559
Source: PubMed

ABSTRACT Different types of ionizing radiation produce different dependences of cancer risk on radiation dose/dose rate. Sparsely ionizing radiation (e.g. γ-rays) generally produces linear or upwardly curving dose responses at low doses, and the risk decreases when the dose rate is reduced (direct dose rate effect). Densely ionizing radiation (e.g. neutrons) often produces downwardly curving dose responses, where the risk initially grows with dose, but eventually stabilizes or decreases. When the dose rate is reduced, the risk increases (inverse dose rate effect). These qualitative differences suggest qualitative differences in carcinogenesis mechanisms. We hypothesize that the dominant mechanism for induction of many solid cancers by sparsely ionizing radiation is initiation of stem cells to a pre-malignant state, but for densely ionizing radiation the dominant mechanism is radiation-bystander-effect mediated promotion of already pre-malignant cell clone growth. Here we present a mathematical model based on these assumptions and test it using data on the incidence of dysplastic growths and tumors in the mammary glands of mice exposed to high or low dose rates of γ-rays and neutrons, either with or without pre-treatment with the chemical carcinogen 7,12-dimethylbenz-alpha-anthracene (DMBA). The model provides a mechanistic and quantitative explanation which is consistent with the data and may provide useful insight into human carcinogenesis.

Download full-text

Full-text

Available from: Igor Shuryak, Jul 07, 2015
1 Follower
 · 
131 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: The variability in radiosensitivity across the human population is governed in part by genetic factors. The ability to predict therapeutic response, identify individuals at greatest risk for adverse clinical responses after therapeutic radiation doses, or identify individuals at high risk for carcinogenesis from environmental or medical radiation exposures has a medical and economic impact on both the individual and society at large. As radiotherapy incorporates particles, particularly particles larger than protons, into therapy, the need for such discriminators, (i.e., biomarkers) will become ever more important. Cellular assays for survival, DNA repair, or chromatid/chromosomal analysis have been used to identify at-risk individuals, but they are not clinically applicable. Newer approaches, such as genome-wide analysis of gene expression or single nucleotide polymorphisms and small copy number variations within chromosomes, are examples of technologies being applied to the discovery process. Gene expression analysis of primary or immortalized human cells suggests that there are distinct gene expression patterns associated with radiation exposure to both low and high linear energy transfer radiations and that those most radiosensitive are discernible by their basal gene expression patterns. However, because the genetic alterations that drive radio response may be subtle and cumulative, the need for large sample sizes of specific cell or tissue types is required. A systems biology approach will ultimately be necessary. Potential biomarkers from cell lines or animal models will require validation in a human setting where possible and before being considered as a credible biomarker some understanding of the molecular mechanism is necessary.
    Health physics 11/2012; 103(5):596-606. DOI:10.1097/HP.0b013e3182692085 · 0.77 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Health effects of security scanners for passenger screening (based on X-ray technology) SCENIHR approved this opinion by written procedure on 26 April 2012 Due to increased concern over terrorist attacks on aircraft, new technologies have been developed to improve the efficiency of security screening of passengers. Some of these technologies use ionising radiation (X-rays). As the hazards related to ionising radiation include the well-known carcinogenic risk, as well as other health effects, the SCENIHR was asked to assess the risks related to use of security scanners for passenger screening that use ionising radiation. The X-ray based security screening technology used in passenger screening relies on two techniques: backscatter or transmission. In the backscatter technique, radiation is reflected from the subject and detected to form an image of the body showing any concealed objects worn on the body. The transmission technique detects X-rays emitted by the equipment that pass through the body of the subject. Any concealed object provides an image by attenuating the radiation. While the backscatter technique can only reveal objects at the surface of the body, the transmission technique also shows objects within the body if their contrast differs sufficiently from the surrounding body fluids or tissue. The effective dose, which takes into consideration the type of radiation and the sensitivity of the body parts exposed, is the best parameter to assess the health risk from ionising radiation. The effective doses per scanned passenger are in the μSv range for the transmission technique and less than 1 μSv for the backscatter technique. The organ doses have generally the same order of magnitude. For persons scanned three times every working day, security scanning would result in an incremental effective dose of approximately 300 μSv (0.3 mSv) per year for the backscatter technique and close to 3 mSv per year for the transmission technique (assuming doses of 0.4 and 4 μSv per scan, respectively). The latter would exceed the dose limit for the general public and hence would not comply with the current radiation protection standards for the very extreme of the most frequently screened and therefore highest exposed group. The former remains within the range characterised as negligible by the US National Council on Radiation Protection and Measurements (NCRP). Short-term (deterministic) health effects due to tissue damage cannot result from the doses delivered by security scanners. The long-term effects of ionising radiation include an increased cancer risk, which is assumed to be directly proportional to the dose received, without a safe threshold. However, direct evidence of an increased cancer risk in humans is only available down to dose levels of 20-100 mSv. For lower doses, the risk estimation rests on linear extrapolation, a reasonable approximation based on both empirical observations and mechanistic inference. Other health effects of ionising radiation, such as hereditary effects, increased risks of cardiovascular and cerebrovascular disease, as well as opacities of the lens of the eye, are not considered pertinent for this opinion as there is no convincing evidence of their occurrence at such low doses. The potential magnitude of cancer risk from doses received from security scanners cannot be estimated, but is likely to remain so low that it cannot be distinguished from the effects of other exposures including both ionising radiation from other sources (including natural) and background risk due to other factors. While the expected health detriment will probably be very close to zero for any single scanned person, the assessment of acceptability of the introduction of the security scanners using X-rays for passenger screening should also take into account the possible effect at the population level. Due to the substantial uncertainty regarding the potential occurrence of any health effects, risks for special groups within the population could not be evaluated meaningfully, although a higher risk related
    First edited by SCENIHR, 12/2012; European Commission., ISBN: ISSN 1831-4783
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: We retrospectively evaluated the risk of second malignancies among 832 patients with inner or central breast cancer treated with conventional external beam schedule (CRT group), or neutron brachytherapy using Californium-252 ((252)Cf) sources and hypofractionated external beam radiotherapy (HRTC group), between 1987 and 1996 at the Institute of Oncology, Vilnius University. Patients were observed until the occurrences of death or development of a second malignancy, or until 31 December 2009, whichever was earlier. Median follow-up time was 10.4 years (range, 1.2-24.1 years). Risk of second primary cancers was quantified using standardized incidence ratios (SIRs). Cox proportional hazards regression models were used to estimate hazard ratios (HRs). There was a significant increase in the risk of second primary cancers compared with the general population (SIR 1.3, 95% CI 1.1-1.5). The observed number of second primary cancers was also higher than expected for breast (SIR 1.8, 95% CI 1.3-2.4) and lung cancer (SIR 3.8, 95% CI 2.0-6.7). For second breast cancer, no raised relative risk was observed during the period ≥10 or more years after radiotherapy. Compared with the CRT group, HRTC patients had a not statistically significant higher risk of breast cancer. Increased relative risks were observed specifically for age at initial diagnosis of <50 years (HR 2.9, 95% CI 1.6-5.2) and for obesity (HR 2.8, 95% CI 1.1-7.2).
    Journal of Radiation Research 02/2013; 54(5). DOI:10.1093/jrr/rrt009 · 1.69 Impact Factor